Analysis on antimicrobial sensitivity of Neisseria meningitidis in China from 2005 to 2019
10.3760/cma.j.cn112150-20200922-01227
- VernacularTitle:2005—2019年中国538株脑膜炎奈瑟菌抗生素耐药性分析
- Author:
Li XU
1
;
Fuyi HAN
;
Dan WU
;
Bingqing ZHU
;
Wanying GAO
;
Yuan GAO
;
Yixing LI
;
Zhujun SHAO
Author Information
1. 中国疾病预防控制中心传染病预防控制所，北京 102206
- Keywords:
Meningitis;
Neisseria meningitidis;
Antimicrobial sensitivity
- From:
Chinese Journal of Preventive Medicine
2021;55(2):207-211
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the antimicrobial resistance characteristics of 538 Neisseria meningitidis isolated from 2005 to 2019 in China. Method:Total of 538 Neisseria meningitidis strains collected from 30 provinces in China from 2005 to 2019. Antimicrobial susceptibility test were performed based on the standards of clinical and laboratory standardization association (CLSI) including 11 recommended antibiotics. Gradient diffusion method was used to detect the antibiotic sensitivity of Neisseria meningitidis. Results:All 538 strains were sensitive to azithromycin, meropenem, chloramphenicol, rifampicin and ceftriaxone. As to other six antibiotics, the antibiotics sensitivity rates were cefotaxime (97.4%, 524 strains), ampicillin (87.7%, 472 strains), penicillin (84.8%, 456 strains), minocycline (95.2%, 512 strains), ciprofloxacin (24.9%, 134 strains) and trimethoprim/sulfamethoxazole (11.2%, 60 strains) respectively.Conclusions:Neisseria meningitidis isolated from 2005-2019 in China were all sensitive to azithromycin, meropenem, chloramphenicol, rifampicin and ceftriaxone. It should highlight Neisseria meningitidis resistant to cefotaxime, ampicillin and penicillin. Ciprofloxacin and sulfamethoxazole are not recommended as the priority choice for clinical treatment and prophylactic medication.
